The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Advances in Brain Tumor Surgery for Glioblastoma in Adults
Open accessAbstract
Glioblastoma (GBM) is the most common primary intracranial neoplasia, and is characterized by its extremely poor prognosis. Despite maximum surgery, chemotherapy, and radiation, the histological heterogeneity of GBM makes total eradication impossible, due to residual cancer cells invading the parenchyma, which is not otherwise seen in radiographic images. Even with gross total resection, the heterogeneity and the dormant nature of brain tumor initiating cells allow for therapeutic evasion, contributing to its recurrence and malignant progression, and severely impacting survival. Visual delimitation of the tumor’s margins with common surgical techniques is a challenge faced by many surgeons. In an attempt to achieve optimal safe resection, advances in approaches allowing intraoperative analysis of cancer and non-cancer tissue have been developed and applied in humans resulting in improved outcomes. In addition, functional paradigms based on stimulation techniques to map the brain’s electrical activity have optimized glioma resection in eloquent areas such as the Broca’s, Wernike’s and perirolandic areas. In this review, we will elaborate on the current standard therapy for newly diagnosed and recurrent glioblastoma with a focus on surgical approaches. We will describe current technologies used for glioma resection, such as awake craniotomy, fluorescence guided surgery, laser interstitial thermal therapy and intraoperative mass spectrometry. Additionally, we will describe a newly developed tool that has shown promising results in preclinical experiments for brain cancer: optical coherence tomography.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Recurrent Glioblastoma: Where we stand
Roy, S., Lahiri, D., Maji, T., & Biswas, J. (2015) · South Asian Journal of Cancer · doi:10.4103/2278-330x.175953 · Cited by 118
RetractedRadiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray Ionization
Takáts, Z., Wiseman, J. M., Gologan, B., & Cooks, R. G. (2004) · Science · doi:10.1126/science.1104404 · Cited by 3,324
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., Lang, F. F., McCutcheon, I. E., Hassenbusch, S. J., Holland, E., et al. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.2.0190 · Cited by 3,091
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8721 · Cited by 2,466
Matrix-assisted ultraviolet laser desorption of non-volatile compounds
Karas, M., Bachmann, D., Bahr, U., & Hillenkamp, F. (1987) · International Journal of Mass Spectrometry and Ion Processes · doi:10.1016/0168-1176(87)87041-6 · Cited by 1,953
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
The development of the Arrhenius equation
Laidler, K. J. (1984) · Journal of Chemical Education · doi:10.1021/ed061p494 · Cited by 1,697
An extent of resection threshold for newly diagnosed glioblastomas: Clinical article
Sanai, N., Polley, M.-Y., McDermott, M. W., Parsa, A. T., & Berger, M. S. (2011) · Journal of Neurosurgery · doi:10.3171/2011.2.jns10998 · Cited by 1,646
Stupp, R., Taillibert, S., Kanner, A. A., Kesari, S., Steinberg, D. M., Toms, S. A., Taylor, L. P., Lieberman, F., Silvani, A., Fink, K. L., et al. (2015) · JAMA · doi:10.1001/jama.2015.16669 · Cited by 1,259
Stoeckli, M., Chaurand, P., Hallahan, D. E., & Caprioli, R. M. (2001) · Nature Medicine · doi:10.1038/86573 · Cited by 1,172
Brown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K. L., Patel, A. S., Rizk, E. B., Suki, D., Sawaya, R., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1373 · Cited by 1,081
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Dowell, J. M., Reardon, D. A., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Wagner, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2309 · Cited by 1,078
Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials
Wong, E. T., Hess, K. R., Gleason, M. J., Jaeckle, K. A., Kyritsis, A. P., Prados, M. D., Levin, V. A., & Yung, W. K. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2572 · Cited by 902 · cited 1×
“Additionally, the resilient nature of these cells to previous treatments displays a worse panorama, exhibiting a survival period between 3 to 9 months (progression-free survival (PFS) of 6 months in 25% of the cases) and a treatment-response rate of only 5 to 10% [25].”
BackgroundSenft, C., Bink, A., Franz, K., Vatter, H., Gasser, T., & Seifert, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70196-6 · Cited by 826
McGirt, M. J., Chaichana, K. L., Gathinji, M., Attenello, F. J., Than, K., Olivi, A., Weingart, J. D., Brem, H., & Quiñones-Hinojosa, A. R. (2009) · Journal of Neurosurgery · doi:10.3171/2008.4.17536 · Cited by 809
Phase II Trial of Gefitinib in Recurrent Glioblastoma
Rich, J. N., Reardon, D. A., Peery, T., Dowell, J. M., Quinn, J. A., Penne, K. L., Wikstrand, C. J., Van Duyn, L. B., Dancey, J. E., McLendon, R. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.110 · Cited by 734
Laws, E. R., Parney, I. F., Huang, W., Anderson, F., Morris, A. M., Asher, A., Lillehei, K. O., Bernstein, M., Brem, H., Sloan, A., et al. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.3.0467 · Cited by 670
Fluorescence-guided surgery with live molecular navigation — a new cutting edge
Nguyen, Q. T., & Tsien, R. Y. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3566 · Cited by 553
Chaichana, K. L., Jusue-Torres, I., Navarro-Ramirez, R., Raza, S. M., Pascual-Gallego, M., Ibrahim, A., Hernandez-Hermann, M., Gomez, L., Ye, X., Weingart, J. D., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not137 · Cited by 505
Self-citationRivera, A. L., Pelloski, C. E., Gilbert, M. R., Colman, H., De La Cruz, C., Sulman, E. P., Bekele, B. N., & Aldape, K. D. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop020 · Cited by 434
Impact of extent of resection for recurrent glioblastoma on overall survival: Clinical article
Bloch, O., Han, S. J., Cha, S., Sun, M. Z., Aghi, M. K., McDermott, M. W., Berger, M. S., & Parsa, A. T. (2012) · Journal of Neurosurgery · doi:10.3171/2012.9.jns12504 · Cited by 432
de Robles, P., Fiest, K. M., Frolkis, A. D., Pringsheim, T., Atta, C., St. Germaine-Smith, C., Day, L., Lam, D., & Jette, N. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou283 · Cited by 338
Kut, C., Chaichana, K. L., Xi, J., Raza, S. M., Ye, X., McVeigh, E. R., Rodriguez, F. J., Quiñones-Hinojosa, A., & Li, X. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010611 · Cited by 323
Current trends in the surgical management and treatment of adult glioblastoma.
Young, R. M., Jamshidi, A. M., Davis, G., & Sherman, J. H. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.05.10 · Cited by 308
Imaging with Mass Spectrometry
Pacholski, M. L., & Winograd, N. (1999) · Chemical Reviews · doi:10.1021/cr980137w · Cited by 302
The Clinical Use of Fluorescein in Neurosurgery: The localization of brain tumors
Moore, G. E., Peyton, W. T., French, L. A., & Walker, W. W. (1948) · Journal of Neurosurgery · doi:10.3171/jns.1948.5.4.0392 · Cited by 300
McGirt, M. J., Than, K. D., Weingart, J. D., Chaichana, K. L., Attenello, F. J., Olivi, A., Laterra, J., Kleinberg, L. R., Grossman, S. A., Brem, H., et al. (2009) · Journal of Neurosurgery · doi:10.3171/2008.5.17557 · Cited by 299
Gaspar, L. E., Fisher, B. J., Macdonald, D. R., Leber, D. V., Halperin, E. C., Schold, S. C., & Cairncross, J. G. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91021-e · Cited by 295
Using the molecular classification of glioblastoma to inform personalized treatment
Olar, A., & Aldape, K. D. (2014) · The Journal of Pathology · doi:10.1002/path.4282 · Cited by 261
Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery
Santagata, S., Eberlin, L. S., Norton, I., Calligaris, D., Feldman, D. R., Ide, J. L., Liu, X., Wiley, J. S., Vestal, M. L., Ramkissoon, S. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404724111 · Cited by 258
Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
Huang, Z., Cheng, L., Guryanova, O. A., Wu, Q., & Bao, S. (2010) · Protein & Cell · doi:10.1007/s13238-010-0078-y · Cited by 248
Attenello, F. J., Mukherjee, D., Datoo, G., McGirt, M. J., Bohan, E., Weingart, J. D., Olivi, A., Quinones-Hinojosa, A., & Brem, H. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0048-2 · Cited by 244
Self-citationMohammadi, A. M., Hawasli, A. H., Rodriguez, A., Schroeder, J. L., Laxton, A. W., Elson, P., Tatter, S. B., Barnett, G. H., & Leuthardt, E. C. (2014) · Cancer Medicine · doi:10.1002/cam4.266 · Cited by 235
Kim, S. S., McCutcheon, I. E., Suki, D., Weinberg, J. S., Sawaya, R., Lang, F. F., Ferson, D., Heimberger, A. B., DeMonte, F., & Prabhu, S. S. (2009) · Neurosurgery · doi:10.1227/01.neu.0000342405.80881.81 · Cited by 233
Current data and strategy in glioblastoma multiforme.
Iacob, G., & Dinca, E. B. (2009) · PubMed Central · Cited by 225
Multiple resections for patients with glioblastoma: prolonging survival: Clinical article
Chaichana, K. L., Zadnik, P., Weingart, J. D., Olivi, A., Gallia, G. L., Blakeley, J., Lim, M., Brem, H., & Quiñones-Hinojosa, A. (2013) · Journal of Neurosurgery · doi:10.3171/2012.9.jns1277 · Cited by 208
Pirro, V., Alfaro, C. M., Jarmusch, A. K., Hattab, E. M., Cohen-Gadol, A. A., & Cooks, R. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706459114 · Cited by 194
Tumor treating fields: A new frontier in cancer therapy
Davies, A. M., Weinberg, U., & Palti, Y. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12112 · Cited by 193
MR‐guided laser‐induced thermal therapy (LITT) for recurrent glioblastomas
Carpentier, A., Chauvet, D., Reina, V., Beccaria, K., Leclerq, D., McNichols, R. J., Gowda, A., Cornu, P., & Delattre, J. (2012) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22025 · Cited by 192
Southwell, D. G., Hervey-Jumper, S. L., Perry, D. W., & Berger, M. S. (2016) · Journal of Neurosurgery · doi:10.3171/2015.5.jns142833 · Cited by 189
Role of Surgical Resection in Low- and High-Grade Gliomas
Hervey-Jumper, S. L., & Berger, M. S. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0284-7 · Cited by 164
Eseonu, C. I., Rincon-Torroella, J., ReFaey, K., Lee, Y. M., Nangiana, J., Vivas-Buitrago, T., & Quiñones-Hinojosa, A. (2017) · Neurosurgery · doi:10.1093/neuros/nyx023 · Cited by 163
Senders, J. T., Muskens, I. S., Schnoor, R., Karhade, A. V., Cote, D. J., Smith, T. R., & Broekman, M. L. D. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-016-3028-5 · Cited by 161
Schwarzmaier, H., Eickmeyer, F., von Tempelhoff, W., Fiedler, V. U., Niehoff, H., Ulrich, S. D., Yang, Q., & Ulrich, F. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.05.010 · Cited by 159
Overview of Cancer Stem Cells and Stemness for Community Oncologists
Lathia, J. D., & Liu, H. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0508-3 · Cited by 154
HMMR Maintains the Stemness and Tumorigenicity of Glioblastoma Stem-like Cells
Tilghman, J. I., Wu, H., Sang, Y., Shi, X., Guerrero‐Cazares, H., Quiñones‐Hinojosa, A., Eberhart, C. G., Laterra, J., & Ying, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2103 · Cited by 142
Quiñones‐Hinojosa, A., Ojemann, S. G., Sanai, N., Dillon, W. P., & Berger, M. S. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.2.0311 · Cited by 137
Chaichana, K. L., Jusué-Torres, I., Lemos, A. M., Gokaslan, A. K., Cabrera‐Aldana, E. E., Ashary, A., Olivi, A., & Quiñones‐Hinojosa, A. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1597-9 · Cited by 122
Martirosyan, N. L., Cavalcanti, D. D., Eschbacher, J. M., Delaney, P. M., Scheck, A. C., Abdelwahab, M. G., Nakaji, P., Spetzler, R. F., & Preul, M. C. (2011) · Journal of neurosurgery · doi:10.3171/2011.8.jns11559 · Cited by 121
Eseonu, C. I., ReFaey, K., García, Ó., John, A. D., Quiñones-Hinojosa, A., & Tripathi, P. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.05.053 · Cited by 99
In vivo intraoperative confocal microscopy for real-time histopathological imaging of brain tumors
Eschbacher, J. M., Martirosyan, N. L., Nakaji, P., Sanai, N., Preul, M. C., Smith, K. A., Coons, S. W., & Spetzler, R. F. (2012) · Journal of neurosurgery · doi:10.3171/2011.12.jns11696 · Cited by 95
Bevacizumab for the Treatment of Glioblastoma
Gil‐Gil, M., Mesía, C., Rey, M., & Bruna, J. (2013) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s8503 · Cited by 95
Intraoperative Speech Mapping in 17 Bilingual Patients Undergoing Resection of a Mass Lesion
Walker, J. A., Quiñones‐Hinojosa, A., & Berger, M. S. (2004) · Neurosurgery · doi:10.1227/01.neu.0000097270.95721.3b · Cited by 85
The Cost of Brain Surgery: Awake vs Asleep Craniotomy for Perirolandic Region Tumors
Eseonu, C. I., Rincón-Torroella, J., ReFaey, K., & Quiñones-Hinojosa, A. (2017) · Neurosurgery · doi:10.1093/neuros/nyx022 · Cited by 78
Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas
Eseonu, C. I., ReFaey, K., García, Ó., Raghuraman, G., & Quiñones‐Hinojosa, A. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.04.002 · Cited by 68
Mansouri, A., Mansouri, S., Hachem, L. D., Klironomos, G., Vogelbaum, M. A., Bernstein, M., & Zadeh, G. M. (2016) · Cancer · doi:10.1002/cncr.30088 · Cited by 65
Improved surgical resection of human brain tumors: Part 1. A preliminary study
Murray, K. J. (1982) · Surgical Neurology · doi:10.1016/0090-3019(82)90298-1 · Cited by 63
Chaichana, K. L., Zaidi, H. A., Pendleton, C. A., McGirt, M. J., Grossman, R., WEINGART, J. D., Olivi, A., Quiñones‐Hinojosa, A., & Brem, H. (2011) · Neurological Research · doi:10.1179/1743132811y.0000000006 · Cited by 58
Eseonu, C. I., Eguia, F. A., ReFaey, K., García, Ó., Rodríguez, F. J., Chaichana, K. L., & Quiñones‐Hinojosa, A. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2486-9 · Cited by 56
Advances in the treatment of newly diagnosed glioblastoma
Theeler, B. J., & Gilbert, M. R. (2015) · BMC Medicine · doi:10.1186/s12916-015-0536-8 · Cited by 51
Chaichana, K. L., Kone, L. B., Bettegowda, C., WEINGART, J. D., Olivi, A., Lim, M. K., Quiñones‐Hinojosa, A., Gallia, G. L., & Brem, H. (2015) · Neurological Research · doi:10.1179/1743132815y.0000000042 · Cited by 50
Lau, D., Hervey‐Jumper, S. L., Han, S. J., & Berger, M. S. (2017) · Journal of neurosurgery · doi:10.3171/2017.1.jns161811 · Cited by 45
Rahmathulla, G., Hovey, Hashemi-Sardraei, & Ahluwalia, M. S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38628 · Cited by 40
Self-citationBevacizumab for the treatment of glioblastoma
Chowdhary, S. A., & Chamberlain, M. C. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.827414 · Cited by 37
Oh, Y. T., Cho, H. J., Kim, J., Lee, J.-H., Rho, K., Seo, Y. J., Choi, Y.-S., Jung, H. J., Song, H. S., Kong, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103327 · Cited by 28
Stöckelmaier, L., Renovanz, M., König, J., Nickel, K., Hickmann, A., Mayer‐Steinacker, R., Nadji‐Ohl, M., Ganslandt, O., Bullinger, L., Wirtz, C. R., et al. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.02.061 · Cited by 22
The Role of Early Resection vs Biopsy in the Management of Low-Grade Gliomas
Markert, J. M. (2012) · JAMA · doi:10.1001/jama.2012.14523 · Cited by 21
Oxygen‐independent degradation of HIF‐α via bioengineered VHL tumour suppressor complex
Sufan, R. I., Moriyama, E. H., Mariampillai, A. L. D., Roche, O., Evans, A. J., Alajez, N. M., Vitkin, I. A., Yang, V. X. D., Liu, F., Wilson, B. C., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900004 · Cited by 21
Intraoperative MRI for the management of brain lesions adjacent to eloquent areas
Reyns, N., Leroy, H., Delmaire, C., Derré, B., Le-Rhun, E., & Lejeune, J. (2017) · Neurochirurgie · doi:10.1016/j.neuchi.2016.12.006 · Cited by 21
Stem cell therapy and its potential role in pituitary disorders
Lara-Velazquez, M. A., Akinduro, O. O., REIMER, R. R., Woodmansee, W. W., & Quiñones‐Hinojosa, A. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000346 · Cited by 7
Self-citationKaloshi, G., Djamandi, P., Cakani, B., Braçe, G., Rroji, A. J., & Petrela, M. (2015) · Tumori Journal · doi:10.5301/tj.5000210 · Cited by 6
Cited by
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wu, W., Klockow, J. L., Zhang, M., Lafortune, F., Chang, E., Jin, L., Wu, Y., & Daldrup-Link, H. E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105780 · Cited by 805
Current FDA-Approved Therapies for High-Grade Malignant Gliomas
Fisher, J. P., & Adamson, D. C. (2021) · Biomedicines · doi:10.3390/biomedicines9030324 · Cited by 316
Deng, G., Peng, X., Sun, Z., Zheng, W., Yu, J., Du, L., Chen, H., Gong, P., Zhang, P., Cai, L., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03824 · Cited by 252
Wang, R., Liang, Q., Zhang, X., Di, Z., Wang, X., & Di, L. (2022) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2022.112505 · Cited by 61
MR1 overexpression correlates with poor clinical prognosis in glioma patients
Kubica, P., Lara-Velazquez, M., Bam, M., Siraj, S., Ong, I., Liu, P., Priya, R., Salamat, S., Brutkiewicz, R. R., & Dey, M. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab034 · Cited by 20
Self-citation
Metadata
- Authors
- Lara-Velazquez, M., Al-Kharboosh, R., Jeanneret, S., Vazquez-Ramos, C., Mahato, D., Tavanaiepour, D., Rahmathulla, G., & Quinones-Hinojosa, A.
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2017-12-20
- Volume
- 7
- Issue
- 12
- Pages
- 166
- ISSN
- 2076-3425 (ISSN-L)
- OpenAlex
- W2777214868
- Cited by
- 285
- References
- 76
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.